CATALYST PHARMACEUTICALS, INC. - COM (CPRX)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 94.1 M
Holdings value Q1 2024: $1.5 B
Value change Q1 2024: +$192 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 257
Number of buys Q1 2024: 152
Number of sells Q1 2024: -106
Average buys Q1 2024 %: +0.001%
Average sells Q1 2024 %: -0.001%
CUSIP: 14888U101

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	94.1 M	$1.5 B	+$192 M	1.07 M	647 K	$15.94	257
2023 Q4	82.2 M	$1.38 B	+$45.2 M	353 K	603 K	$16.81	255
2023 Q3	80.5 M	$941 M	-$23.7 M	470 K	500 K	$11.69	251
2023 Q2	82 M	$1.1 B	-$95.3 M	800 K	2.57 M	$13.44	240
2023 Q1	88.3 M	$1.46 B	+$71 M	1.6 M	18.9 M	$16.58	256
2022 Q4	83.7 M	$1.56 B	-$9.96 M	1.87 M	5.14 M	$18.60	250
2022 Q3	81.6 M	$1.05 B	+$185 M	873 K	1.01 M	$12.83	216
2022 Q2	73.8 M	$515 M	+$38.3 M	134 K	238 K	$7.01	170
2022 Q1	67.7 M	$560 M	+$34.5 M	165 K	228 K	$8.29	175
2021 Q4	65.2 M	$441 M	+$3.78 M	0	150 K	$6.77	156
2021 Q3	65.1 M	$345 M	-$1.8 M	372 K	122 K	$5.30	137
2021 Q2	65.3 M	$376 M	-$10.2 M	1.76 M	505 K	$5.75	135
2021 Q1	67.6 M	$311 M	+$11.3 M	187 K	387 K	$4.61	130
2020 Q4	66.6 M	$222 M	-$12.7 M	252 K	190 K	$3.34	129
2020 Q3	67.9 M	$202 M	+$814 K	265 K	452 K	$2.97	137
2020 Q2	64.7 M	$299 M	-$3 M	55 K	558 K	$4.62	136
2020 Q1	63 M	$243 M	+$12.2 M	183 K	542 K	$3.85	124
2019 Q4	60 M	$225 M	-$31.6 M	242 K	70 K	$3.75	125
2019 Q3	61.5 M	$327 M	+$8.44 M	757 K	216 K	$5.31	112
2019 Q2	61.5 M	$236 M	-$4.81 M	1.28 M	731 K	$3.84	98
2019 Q1	61.5 M	$313 M	+$64.1 M	604 K	571 K	$5.10	86
2018 Q4	49.1 M	$94.2 M	-$22 M	28 K	0	$1.92	83
2018 Q3	51 M	$193 M	-$11.4 M	382 K	906 K	$3.78	94
2018 Q2	54 M	$168 M	+$2.66 M	79 K	179 K	$3.12	94
2018 Q1	54.7 M	$131 M	-$11.1 M	66 K	60 K	$2.39	96
2017 Q4	56.1 M	$219 M	+$80.4 M	108 K	108 K	$3.91	105
2017 Q3	35.6 M	$89.6 M	+$4.34 M	75 K	83 K	$2.52	76
2017 Q2	33.9 M	$93.7 M	+$24.7 M	36 K	408 K	$2.76	68
2017 Q1	25.3 M	$49.3 M	+$4.79 M		38 K	$1.95	51
2016 Q4	23.8 M	$25 M	+$503 K			$1.05	48
2016 Q3	23.3 M	$25.4 M	-$1.71 M			$1.09	44
2016 Q2	25.3 M	$18 M	-$12.3 M			$0.71	55
2016 Q1	36.9 M	$43.2 M	-$15.8 M			$1.17	69
2015 Q4	42.3 M	$104 M	-$6.36 M			$2.45	82
2015 Q3	44.7 M	$134 M	+$1.58 M	0	0	$3.00	88
2015 Q2	43.3 M	$179 M	+$18.6 M	61 K	217 K	$4.13	85
2015 Q1	38.8 M	$168 M	+$54.5 M	63 K	2 K	$4.33	64
2014 Q4	27.2 M	$80.7 M	+$8.34 M	0	1 K	$2.97	48
2014 Q3	23.5 M	$78 M	+$8.08 M	119 K	1.13 M	$3.32	51
2014 Q2	22.2 M	$56.1 M	+$29.9 M	1 K	79 K	$2.53	45
2014 Q1	10.3 M	$23.4 M	+$2.87 M	3 K	3 K	$2.26	35